Andrew D. White

2.7k citations

37 papers · 2.0k indexed · 2 hit papers · h-index 18

Molecular Biology top 10%
Organic Chemistry top 5%
Cellular and Molecular Neuroscience top 10%
Physiology top 10%
Cancer Research top 10%

Co-authors: Steven V. Ley William P. Griffith Guy Perkins Akos A. Gerencser Ella Bossy‐Wetzel Blaise Bossy Mark H. Ellisman Jean‐Claude Martinou
Topics: Receptor Mechanisms and Signaling (10 papers)Pharmacological Receptor Mechanisms and Effects (5 papers)Neuropeptides and Animal Physiology (5 papers)
Cited by: Organic Chemistry Biochemistry Clinical Biochemistry
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry The EMBO Journal
Partner nations: United States France Poland

In The Last Decade

Andrew D. White

37 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preparation and use of tetra-n-butylammonium per-ruthenate (TBAP reagent) and tetra-n-propylammonium per-ruthenate (TPAP reagent) as new catalytic oxidants for alcohols

1987 603 citations Andrew D. White et al. profile →
Nitric oxide‐induced mitochondrial fission is regulated by dynamin‐related GTPases in neurons

2006 561 citations Hua Yuan, Akos A. Gerencser et al. The EMBO Journal profile →

Peers

Countries citing papers authored by Andrew D. White

Since Specialization

Citations

This map shows the geographic impact of Andrew D. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. White more than expected).

Fields of papers citing papers by Andrew D. White

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. White. The network helps show where Andrew D. White may publish in the future.

Co-authorship network of co-authors of Andrew D. White

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. White. A scholar is included among the top collaborators of Andrew D. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. White. Andrew D. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor 2023 ·Blood ·(unknown),Adriana Yamaguchi,(unknown),Sylviane Lambert,(unknown),(unknown),Catherine Luke,(unknown),T. Andrea,Andrew D. White,Niklas Bergh,Björn Dahlöf,Michael Holinstat	9
2	Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity 2022 ·Nature Metabolism ·Işın Çakır,(unknown),(unknown),Rushita A. Bagchi,Masoud Ghamari‐Langroudi,Danielle T. Porter,(unknown),M. Litt,(unknown),Susan E. Hagen,Pil H. Lee,Andrew D. White,Jiandie D. Lin,Timothy A. McKinsey,Roger D. Cone	46
3	An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation 2021 ·Blood ·Lei Yu,(unknown),(unknown),(unknown),Yu Wang,Sharon Singh,Natee Jearawiriyapaisarn,Andrew D. White,Takashi Moriguchi,Rami Khoriaty,Masayuki Yamamoto,Michael G. Rosenfeld,(unknown),John H. Bushweller,Kim‐Chew Lim,James Douglas Engel	15
4	Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edema 2020 ·Bioorganic & Medicinal Chemistry ·Xuwen Liu,Michael W. Wilson,Kun Liu,Pil H. Lee,Larisa Yeomans,Susan E. Hagen,Cheng‐mao Lin,Bo Wen,Duxin Sun,Andrew D. White,Hollis D. Showalter,David A. Antonetti	1
5	S-3-Carboxypropyl-l-cysteine specifically inhibits cystathionine γ-lyase–dependent hydrogen sulfide synthesis 2019 ·Journal of Biological Chemistry ·Pramod Kumar Yadav,Victor Vitvitsky,Hanseong Kim,Andrew D. White,Uhn‐Soo Cho,Ruma Banerjee	15
6	cis-1-Oxo-heterocyclyl-4-amido cyclohexane derivatives as NPY5 receptor antagonists 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Bin Chen,Chien‐An Chen,Darı́o Doller,(unknown),Yu Jiang,John Peterson,Michael Sabio,(unknown),Andrew D. White,Lingyun Wu,Rajinder Bhardwaj,Gamini Chandrasena,(unknown),Xinyan Huang	3
7	Fused thiazolyl alkynes as potent mGlu5 receptor positive allosteric modulators 2013 ·Bioorganic & Medicinal Chemistry Letters ·Mathivanan Packiarajan,(unknown),(unknown),Allen T. Hopper,Andrew D. White,Gamini Chandrasena,(unknown),Robbin Brodbeck,Albert J. Robichaud	6
8	Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators 2012 ·Bioorganic & Medicinal Chemistry Letters ·Mathivanan Packiarajan,(unknown),(unknown),Andrew D. White,Gamini Chandrasena,(unknown),Robbin Brodbeck,Albert J. Robichaud	12
9	N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators 2012 ·Bioorganic & Medicinal Chemistry Letters ·Mathivanan Packiarajan,(unknown),(unknown),Andrew D. White,Gamini Chandrasena,(unknown),Robbin Brodbeck,Albert J. Robichaud	17
10	Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity 2012 ·Cell Death and Differentiation ·Yulia E. Kushnareva,Akos A. Gerencser,Blaise Bossy,(unknown),Andrew D. White,(unknown),MH Ellisman,Guy Perkins,Ella Bossy‐Wetzel	92
11	Hydration of Zwitterionic Glycine Betaine and Analogues Through Molecular Simulation 2011 ·Biophysical Journal ·Andrew D. White,Shaoyi Jiang	1
12	Strategies to lower the Pgp efflux liability in a series of potent indole azetidine MCHR1 antagonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·Kai Lǚ,Yu Jiang,Bin Chen,(unknown),Gil Ma,Mathivanan Packiarajan,Gamini Chandrasena,Andrew D. White,Kenneth Jones,(unknown),(unknown)	11
13	Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder 2011 ·Bioorganic & Medicinal Chemistry Letters ·Douglas S. Johnson,Chung Sik Choi,(unknown),David A. Favor,Joseph T. Repine,Andrew D. White,Hyacinth C. Akunne,Lawrence W. Fitzgerald,(unknown),Bradley J. Snyder,Steven Z. Whetzel,Liming Zhang,Kevin A. Serpa	19
14	6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics 2010 ·Bioorganic & Medicinal Chemistry Letters ·David A. Favor,(unknown),Andrew D. White,Lawrence W. Fitzgerald,Vincent E. Groppi,Kevin A. Serpa	8
15	Synthesis of monofluorinated 1-(naphthalen-1-yl)piperazines 2007 ·Tetrahedron Letters ·Joseph T. Repine,Douglas S. Johnson,Andrew D. White,David A. Favor,Michael A. Stier,(unknown),(unknown),(unknown),Samarendra N. Maiti	11
16	Nitric oxide‐induced mitochondrial fission is regulated by dynamin‐related GTPases in neuronsbreakdown → 2006 ·The EMBO Journal ·(unknown),Hua Yuan,Akos A. Gerencser,Géraldine Liot,Yulia Kushnareva,(unknown),Imre Kovács,(unknown),(unknown),Jiankun Cui,Andrew D. White,Blaise Bossy,Jean‐Claude Martinou,Richard J. Youle,Stuart A. Lipton,Mark H. Ellisman,Guy Perkins,Ella Bossy‐Wetzel	561
17	A Rationalization of the Acidic pH Dependence for Stromelysin-1 (Matrix Metalloproteinase-3) Catalysis and Inhibition 2000 ·Journal of Biological Chemistry ·Linda L. Johnson,A.G. Pavlovsky,Adam R. Johnson,(unknown),(unknown),Daniel F. Ortwine,(unknown),Andrew D. White,Donald Hupe	64
18	X‐ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivity 1999 ·Protein Science ·A.G. Pavlovsky,Mark Williams,(unknown),Daniel F. Ortwine,(unknown),Andrew D. White,V. Dhanaraj,Bruce D. Roth,(unknown),Donald Hupe,Christine Humblet,Tom L. Blundell	65
19	Emerging Therapeutic Advances for the Development of Second Generation Matrix Metalloproteinase Inhibitors 1997 ·Current Pharmaceutical Design ·Andrew D. White,Thomas Bocan,Peter A. Boxer,Janet T. Peterson,Denis J. Schrier	37
20	A method utilizing human lymphocytes with in vitro metabolic activation for assessing chemical mutagenicity by sister-chromatid exchange analysis 1980 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·Andrew D. White,(unknown)	30

About Andrew D. White

Andrew D. White is a scholar working on Biochemistry, Cellular and Molecular Neuroscience and Molecular Biology, having authored 37 papers that have together received 2.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neuropeptides and Animal Physiology (5 papers). The work is most often cited by research in Organic Chemistry (666 citations), Biochemistry (135 citations) and Clinical Biochemistry (125 citations). Andrew D. White has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Steven V. Ley, William P. Griffith, Guy Perkins, Akos A. Gerencser, Ella Bossy‐Wetzel, Blaise Bossy, Mark H. Ellisman, Jean‐Claude Martinou, Jiankun Cui and Hua Yuan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact